As on Thursday, Mira Pharmaceuticals Inc (NASDAQ: MIRA) started slowly as it slid -0.45% to $2.19, before settling in for the price of $2.20 at the close. Taking a more long-term approach, MIRA posted a 52-week range of $0.51-$6.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 21.88%. This publicly-traded company’s shares outstanding now amounts to $14.78 million, simultaneously with a float of $9.96 million. The organization now has a market capitalization sitting at $32.37 million. At the time of writing, stock’s 50-day Moving Average stood at $1.37, while the 200-day Moving Average is $1.19.
Mira Pharmaceuticals Inc (MIRA) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Drug Manufacturers – General industry. Mira Pharmaceuticals Inc’s current insider ownership accounts for 32.64%, in contrast to 4.97% institutional ownership. Preceding that transaction, on Aug 28 ’24, Company’s 10% Owner sold 200,000 for 1.96, making the whole transaction’s value amount to 392,000. This particular insider is now the holder of 2,540,270 in total.
Mira Pharmaceuticals Inc (MIRA) Earnings and Revenue Records
Mira Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 21.88% and is forecasted to reach -0.56 in the upcoming year.
Mira Pharmaceuticals Inc (NASDAQ: MIRA) Trading Performance Indicators
Let’s observe the current performance indicators for Mira Pharmaceuticals Inc (MIRA). It’s Quick Ratio in the last reported quarter now stands at 3.68. The Stock has managed to achieve an average true range (ATR) of 0.23.
In the same vein, MIRA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.84, a figure that is expected to reach -0.14 in the next quarter, and analysts are predicting that it will be -0.56 at the market close of one year from today.
Technical Analysis of Mira Pharmaceuticals Inc (MIRA)
Through scrutinizing the latest numbers posted by the [Mira Pharmaceuticals Inc, MIRA], it can be observed that its last 5-days Average volume of 10.98 million was better the volume of 2.27 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 74.87% While, its Average True Range was 0.27.
Raw Stochastic average of Mira Pharmaceuticals Inc (MIRA) in the period of the previous 100 days is set at 37.33%, which indicates a major fall in contrast to 75.97% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 128.35% that was lower than 353.45% volatility it exhibited in the past 100-days period.
